Human complement factor H: expression of an additional truncated gene product of 43 kDa in human liver
- 1 January 1987
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 17 (10), 1485-1489
- https://doi.org/10.1002/eji.1830171015
Abstract
The human complement factor H is an important factor in the control of the alternative pathway and also induces the stimulation of B cells and macrophages in vitro. Using a human factor H cDNA clone as probe, two factor H‐specific transcripts of 4.4 and 1.8 kb were detected in four human livers. Both mRNAs were found independently of the expression of an acute phase marker SAA, in these livers, indicating that their presence is not linked to an acute phase state. The shorter transcript was cloned in two cDNA plasmids H‐19 and H‐20, lacking only seven amino acids of the N‐terminus of the mature factor H protein. The deduced protein sequence showed that this protein is identical to the N‐terminal portion of the large classical factor H of 150 kDa mol. mass. Parallel to the finding that the N‐terminal sequence of factor H is expressed by two distinct mRNA species, evidence is presented that the C‐terminal sequence is also contained on two different transcripts, the common 4.4‐kb mRNA and an additional 1.0‐kb mRNA. A novel, short form of human complement factor H of 43 kDa was detected in human sera which represents the translation product of the 1.8‐kb factor H‐specific mRNA detected in human liver. Five distinct epitopes detected with 6 monoclonal antibodies are present on both the 150‐kDa factor H protein and the truncated 43‐kDa molecule. We conclude that additional H‐specific mRNAs are found in human liver and that at least one of them is translated yielding a truncated form of factor H.This publication has 23 references indexed in Scilit:
- Human complement factor H: isolation of cDNA clones and partial cDNA sequence of the 38‐kDa tryptic fragment containing the binding site for C3bEuropean Journal of Immunology, 1986
- Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNABiochemistry, 1985
- Characterization of the lymphocyte membrane receptor for factor H (β1H- globulin) with an antibody to anti-factor H idiotypeThe Journal of Experimental Medicine, 1982
- Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin.The Journal of Experimental Medicine, 1980
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Changes in Human Serum Amyloid A and C-Reactive Protein after Etiocholanolone-Induced InflammationJournal of Clinical Investigation, 1978
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.The Journal of Experimental Medicine, 1977
- Modulation of the alternative complement pathways by beta 1 H globulin.The Journal of Experimental Medicine, 1976
- Une micro-méthode de l’immuno-électrophorèseInternational Archives of Allergy and Immunology, 1955